Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 385

1.

Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.

Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DF, Schumann G, Machulla HJ, Bares R, Mann K.

Arch Gen Psychiatry. 2005 Jan;62(1):57-64. Erratum in: Arch Gen Psychiatry. 2005 Sep;62(9):983. Braus, Dieter H [corrected to Braus, Dieter F].

PMID:
15630073
2.

Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving.

Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grüsser SM, Flor H, Braus DF, Buchholz HG, Gründer G, Schreckenberger M, Smolka MN, Rösch F, Mann K, Bartenstein P.

Am J Psychiatry. 2004 Oct;161(10):1783-9. Erratum in: Am J Psychiatry. 2004 Dec;161(12):2344. Grüsser-Sinopoli, Sabine M [corrected to Grüsser, Sabine M].

PMID:
15465974
3.

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.

Bencherif B, Wand GS, McCaul ME, Kim YK, Ilgin N, Dannals RF, Frost JJ.

Biol Psychiatry. 2004 Feb 1;55(3):255-62.

PMID:
14744466
4.

Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.

Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Rösch F, Vernaleken I, Schäfer WM, Gründer G.

Biol Psychiatry. 2011 Oct 15;70(8):770-6. doi: 10.1016/j.biopsych.2011.05.035. Epub 2011 Jul 29.

PMID:
21802658
5.

Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.

Kennedy SE, Koeppe RA, Young EA, Zubieta JK.

Arch Gen Psychiatry. 2006 Nov;63(11):1199-208.

PMID:
17088500
6.

Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.

Heinz A, Siessmeier T, Wrase J, Buchholz HG, Gründer G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rösch F, Mann K, Bartenstein P.

Am J Psychiatry. 2005 Aug;162(8):1515-20.

PMID:
16055774
7.

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.

Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME.

Neuropsychopharmacology. 2008 Feb;33(3):653-65. Epub 2007 May 9.

8.

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.

Anton RF, Moak DH, Latham PK.

Arch Gen Psychiatry. 1996 Mar;53(3):225-31. Erratum in: Arch Gen Psychiatry 1996 Jul;53(7):576.

PMID:
8611059
9.

Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.

Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, Swift RM, Addolorato G.

Alcohol. 2008 Aug;42(5):375-81. doi: 10.1016/j.alcohol.2008.03.128. Epub 2008 May 16.

PMID:
18486430
10.

Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.

Weerts EM, Wand GS, Kuwabara H, Xu X, Frost JJ, Wong DF, McCaul ME.

Addict Biol. 2014 Jul;19(4):733-42. doi: 10.1111/adb.12022. Epub 2012 Dec 18.

11.

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.

Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID.

Psychopharmacology (Berl). 2001 Feb;154(1):23-7.

PMID:
11292002
12.

High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors.

Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK.

Arch Gen Psychiatry. 2006 Sep;63(9):999-1008.

PMID:
16953002
13.

The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.

Alcohol. 2012 Sep;46(6):511-7. doi: 10.1016/j.alcohol.2012.04.006. Epub 2012 Jun 18.

14.

Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification.

Catafau AM, Etcheberrigaray A, Perez de los Cobos J, Estorch M, Guardia J, Flotats A, Bernà L, Marí C, Casas M, Carrió I.

J Nucl Med. 1999 Jan;40(1):19-24.

15.

Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Weerts EM, Wand GS, Kuwabara H, Munro CA, Dannals RF, Hilton J, Frost JJ, McCaul ME.

Alcohol Clin Exp Res. 2011 Dec;35(12):2162-73. doi: 10.1111/j.1530-0277.2011.01565.x. Epub 2011 Jun 20.

16.

Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.

Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ.

Nat Med. 1996 Nov;2(11):1225-9.

PMID:
8898749
17.

Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.

Cowen MS, Rezvani AH, Jarrott B, Lawrence AJ.

Alcohol Clin Exp Res. 1999 Jun;23(6):1008-14.

PMID:
10397284
18.

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ.

Psychopharmacology (Berl). 2002 Feb;160(1):19-29. Epub 2002 Jan 22.

PMID:
11862370
19.

Imaging opiate receptors in the human brain by positron tomography.

Frost JJ, Wagner HN Jr, Dannals RF, Ravert HT, Links JM, Wilson AA, Burns HD, Wong DF, McPherson RW, Rosenbaum AE, et al.

J Comput Assist Tomogr. 1985 Mar-Apr;9(2):231-6.

PMID:
2982931
20.

Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography.

Mayberg HS, Sadzot B, Meltzer CC, Fisher RS, Lesser RP, Dannals RF, Lever JR, Wilson AA, Ravert HT, Wagner HN Jr, et al.

Ann Neurol. 1991 Jul;30(1):3-11.

PMID:
1656846
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk